12 research outputs found
Wild bitter gourd improves metabolic syndrome: A preliminary dietary supplementation trial
<p>Abstract</p> <p>Background</p> <p>Bitter gourd (<it>Momordica charantia </it>L.) is a common tropical vegetable that has been used in traditional or folk medicine to treat diabetes. Wild bitter gourd (WBG) ameliorated metabolic syndrome (MetS) in animal models. We aimed to preliminarily evaluate the effect of WBG supplementation on MetS in Taiwanese adults.</p> <p>Methods</p> <p>A preliminary open-label uncontrolled supplementation trial was conducted in eligible fulfilled the diagnosis of MetS from May 2008 to April 2009. A total of 42 eligible (21 men and 21 women) with a mean age of 45.7 ± 11.4 years (23 to 63 years) were supplemented with 4.8 gram lyophilized WBG powder in capsules daily for three months and were checked for MetS at enrollment and follow-up monthly. After supplementation was ceased, the participants were continually checked for MetS monthly over an additional three-month period. MetS incidence rate were analyzed using repeated-measures generalized linear mixed models according to the intention-to-treat principle.</p> <p>Results</p> <p>After adjusting for sex and age, the MetS incidence rate (standard error, <it>p </it>value) decreased by 7.1% (3.7%, 0.920), 9.5% (4.3%, 0.451), 19.0% (5.7%, 0.021), 16.7% (5.4%, 0.047), 11.9% (4.7%, 0.229) and 11.9% (4.7%, 0.229) at visit 2, 3, 4, 5, 6, and 7 compared to that at baseline (visit 1), respectively. The decrease in incidence rate was highest at the end of the three-month supplementation period and it was significantly different from that at baseline (<it>p </it>= 0.021). The difference remained significant at end of the 4th month (one month after the cessation of supplementation) (<it>p </it>= 0.047) but the effect diminished at the 5th and 6th months after baseline. The waist circumference also significantly decreased after the supplementation (<it>p </it>< 0.05). The WBG supplementation was generally well-tolerated.</p> <p>Conclusion</p> <p>This is the first report to show that WBG improved MetS in human which provides a firm base for further randomized controlled trials to evaluate the efficacy of WBG supplementation.</p
A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo
Aqueous Viscum album L. extracts are widely used in complementary cancer
medicine. Hydrophobic triterpene acids also possess anti-cancer properties,
but due to their low solubility they do not occur in significant amounts in
aqueous extracts. Using cyclodextrins we solubilised mistletoe triterpenes
(mainly oleanolic acid) and investigated the effect of a mistletoe whole plant
extract on human acute myeloid leukaemia cells in vitro, ex vivo and in vivo.
Single Viscum album L. extracts containing only solubilised triterpene acids
(TT) or lectins (viscum) inhibited cell proliferation and induced apoptosis in
a dose-dependent manner in vitro and ex vivo. The combination of viscum and TT
extracts (viscumTT) enhanced the induction of apoptosis synergistically. The
experiments demonstrated that all three extracts are able to induce apoptosis
via caspase-8 and -9 dependent pathways with down-regulation of members of the
inhibitor of apoptosis and Bcl-2 families of proteins. Finally, the acute
myeloid leukaemia mouse model experiment confirmed the therapeutic
effectiveness of viscumTT-treatment resulting in significant tumour weight
reduction, comparable to the effect in cytarabine-treated mice. These results
suggest that the combination viscumTT may have a potential therapeutic value
for the treatment AML